Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjogren's Syndrome - Open-label Extension Phase of a Randomized Controlled Phase III Trial

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Number of pages3
JournalArthritis & Rheumatology
Volume71
Publication statusPublished - Oct-2019

Cite this